Enterprise Value
20.31M
Cash
88.52M
Avg Qtr Burn
-9.579M
Short % of Float
2.58%
Insider Ownership
40.01%
Institutional Own.
50.52%
Qtr Updated
03/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Epetraborole Details Mycobacterium avium complex lung disease, Lung disease | Phase 2/3 Data readout |